Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
- Resource Type
- Article
- Source
- In
Acta Pharmaceutica Sinica B September 2024 14(9):3949-3963 - Subject
- Language
- ISSN
- 2211-3835